3020-OL:HK:HK-X DBMSCIUSA (HKD)

COMMON STOCK | Other |

Last Closing

USD 1160

Change

-0.50 (-0.04)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-18 )

Largest Industry Peers for Other

ETFs Containing 3020-OL:HK

IHF iShares U.S. Healthcare P.. 9.59 % 0.43 %

-0.40 (-0.35%)

USD 0.82B
TETF 6.19 % 0.64 %

N/A

N/A
WBIL WBI BullBear Quality 3000.. 4.55 % 1.07 %

+0.05 (+-0.35%)

USD 0.04B
IAI iShares U.S. Broker-Deale.. 4.28 % 0.42 %

+0.70 (+-0.35%)

USD 0.49B
CBUF:XETRA iShares MSCI World Health.. 3.51 % 0.00 %

N/A

USD 1.13B
HDIV 2.83 % 0.00 %

N/A

N/A
SPVU Invesco S&P 500® Enhance.. 2.73 % 0.16 %

-0.52 (-0.35%)

USD 0.11B
UC96:LSE UBS (Irl) ETF plc - Facto.. 2.37 % 0.00 %

-27.00 (-0.35%)

USD 0.35B
UPVL:LSE UBS (Irl) ETF plc - Facto.. 2.37 % 0.00 %

-23.25 (-0.35%)

USD 8.21M
UBUS:F UBS (Irl) ETF Public Limi.. 2.35 % 0.00 %

N/A

USD 0.33B
UBUW:F UBS (Irl) ETF Public Limi.. 2.35 % 0.00 %

N/A

USD 0.02B
UBUS:XETRA UBS (Irl) ETF plc - Facto.. 2.35 % 0.00 %

N/A

USD 0.49B
UBUW:XETRA UBS (Irl) ETF plc - Facto.. 2.35 % 0.00 %

N/A

USD 0.05B
NSGE:CA NBI Sustainable Global Eq.. 2.32 % 0.00 %

N/A

CAD 0.53B
XHS SPDR® S&P Health Care Se.. 2.13 % 0.35 %

-0.13 (-0.35%)

USD 0.08B
FXH First Trust Health Care A.. 2.13 % 0.63 %

+0.59 (+-0.35%)

USD 1.33B
SPVM Invesco S&P 500 Value wit.. 1.78 % 0.39 %

-0.15 (-0.35%)

USD 0.09B
RYH 1.72 % 0.40 %

N/A

N/A
HONR 1.20 % 0.65 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.64 % 0.40 %

-0.12 (-0.35%)

CAD 0.35B
SMD 0.45 % 0.10 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 5.46M
DUSA 0.00 % 0.63 %

N/A

N/A
DRFU:CA Desjardins RI USA Multifa.. 0.00 % 0.57 %

N/A

CAD 5.97M
RYF 0.00 % 0.40 %

N/A

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

-1.25 (-0.35%)

USD 4.20B
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

-0.23 (-0.35%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.51% 75% C 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.51% 76% C+ 77% C+
Trailing 12 Months  
Capital Gain 24.01% 90% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.01% 89% A- 86% B+
Trailing 5 Years  
Capital Gain 88.01% 86% B+ 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 88.01% 86% B+ 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 14.44% 80% B- 79% B-
Dividend Return 14.44% 78% C+ 78% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.57% 72% C 72% C
Risk Adjusted Return 73.82% 98% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike